Antibiotic overuse and misuse have become a global concern, and India's antibiotic prescription patterns are under the spotlight. A recent study published in The Lancet Public Health reveals some alarming trends, suggesting that India may be over-relying on powerful antibiotics, while underutilizing simpler and more accessible ones. This raises important questions about the country's approach to infection treatment and the potential consequences for public health.
The Antibiotic Classification Conundrum
The World Health Organization (WHO) has categorized antibiotics into three groups: 'access', 'watch', and 'reserve'. 'Access' antibiotics are the first-choice for common infections, carrying a lower risk of resistance. 'Watch' antibiotics, on the other hand, are broad-spectrum and should be reserved for specific infections when simpler antibiotics are ineffective. Lastly, 'reserve' antibiotics are the last resort, used to treat multidrug-resistant infections.
India's Antibiotic Consumption
The study estimates that India ideally requires 14.7 defined daily doses (DID) of antibiotics per 1,000 people per day. This includes 7.8 DID of 'access' antibiotics, 6 DID of 'watch' antibiotics, and 0.99 DID of 'reserve' antibiotics. However, India's actual consumption paints a different picture. The country currently uses 18.3 DID overall, with a significant portion (9.3 DID) belonging to the 'watch' category. This suggests that a large number of patients are being exposed to these powerful antibiotics unnecessarily.
Global Perspective
The study analyzed antibiotic use across 186 countries, representing 99.8% of the world's population. It found that nearly three-fourths of countries, including India, are using more antibiotics overall than necessary. Furthermore, almost every country is overusing antibiotics that contribute to antimicrobial resistance. This global trend highlights the urgent need for better antibiotic stewardship and awareness.
India's Unique Challenges
India's higher burden of infectious diseases and antimicrobial resistance means it legitimately requires more 'watch' antibiotics than many other countries. However, the study also suggests that 'reserve' antibiotics are being underused, despite the country's resistance burden. Additionally, antibiotics that are no longer recommended continue to be prescribed more than expected. This indicates a lack of adherence to updated guidelines and a potential gap in medical education and awareness.
Implications and Way Forward
The findings of this study have significant implications for India's healthcare system. Strategies to improve antibiotic use should focus on ensuring populations have access to the right antibiotics at the right time, while reducing unnecessary use. This requires a multi-faceted approach, including better antimicrobial stewardship, awareness campaigns, and updated medical guidelines. Additionally, there is a need to address the underlying reasons for the overuse of certain antibiotics, such as ceftriaxone, cefixime, and azithromycin, through targeted interventions.
Conclusion
Antibiotic overuse and misuse are complex issues with far-reaching consequences. India's unique challenges, including a high burden of infectious diseases and antimicrobial resistance, require tailored solutions. By addressing these issues head-on, India can play a crucial role in global efforts to combat antimicrobial resistance and ensure access to effective antibiotics for those who truly need them.
